Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript

Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.29824 EPS, expectations were $0.09. Amneal Pharmaceuticals, Inc.

Related Keywords

South Africa ,Mexico ,China ,Canada ,India ,Philippines ,California ,United States ,New Jersey ,State Of California ,Saudi Arabia ,America ,American ,Americans ,David Amsellem ,Chintu Patel ,Chirag Patel ,Balaji Prasad ,Jason Daly ,Piper Sandler ,Tony Dimeo ,Chris Schott ,Tasos Konidaris ,Joe Renda ,Randy Boyer ,Leszek Sulewski ,Goldman Sachs ,Anthony ,Amneal Pharmaceuticals ,Amneal Pharmaceuticals First Quarter ,Amneal Pharmaceuticals Inc ,Barclays ,Parkinson Foundation ,Call Transcript May ,Investor Relations ,Cautionary Statements ,Forward Looking Statements ,Chief Legal ,Trucking Stocks ,Profitable Stocks ,Nathan Rich ,